Oxcarbazepine in Rapid Benzodiazepine Detoxification
- 1 January 2008
- journal article
- research article
- Published by Taylor & Francis Ltd in The American Journal of Drug and Alcohol Abuse
- Vol. 34 (5), 534-540
- https://doi.org/10.1080/00952990802149021
Abstract
Objective: This study aims at evaluating the tolerability and efficacy of the antiepileptic drug oxcarbazepine in benzodiazepine detoxification in ten patients. Methods: In this case study of an inpatient withdrawal program, each of the ten patients was detoxified using oxcarbazepine and completed withdrawal successfully without the occurrence of withdrawal symptoms. The detoxification program followed an outlined dosage scheme with oxcarbazepine increase and benzodiazepine tapering. Results: The rapidity of benzodiazepine detoxification using oxcarbazepine was remarkable, benzodiazepine withdrawal being completed in as little as 11 days. Conclusions: The results support the assumption that oxcarbazepine is a valuable drug for inpatient benzodiazepine withdrawal programs.Keywords
This publication has 16 references indexed in Scilit:
- Oxcarbazepine at High Dosages for the Treatment of Alcohol DependenceThe American Journal on Addictions, 2007
- High and low dosage oxcarbazepine versus naltrexone for the prevention of relapse in alcohol-dependent patientsHuman Psychopharmacology: Clinical and Experimental, 2007
- A Pilot Study of Oxcarbazepine Versus Acamprosate in Alcohol‐Dependent PatientsAlcohol: Clinical and Experimental Research, 2006
- Oxcarbazepine in Alcohol Relapse PreventionPharmacopsychiatry, 2004
- What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?Epilepsy & Behavior, 2004
- Anticonvulsant drugs in the treatment of substance withdrawalDrugs of Today, 2004
- OxcarbazepineExpert Opinion on Pharmacotherapy, 2002
- Treatment of Epilepsy in the New MillenniumPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2000
- Safety and Efficacy of Oxcarbazepine: Results of Randomized, Double‐Blind TrialsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2000
- Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal symptoms and taper outcomePsychopharmacology, 1999